Articles

Podcasts

Videos

Cardiology

Cardiology condition center page is a comprehensive resource for clinical news and insights on cardiovascular and cardiometabolic diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for heart disease and cardiovascular events, as well as associated diabetes, renal failure, and more...

The Yale Associate Chief of Cardiovascular Medicine discusses improved use of available drug classes, as well as the potential approval for omecamtiv mecarbil.

Nihar Desai, MD, MPH: Improving PCSK9 Inhibitor Use, Guiding Heart Failure Care & ACC 2022 Headlines

An expert physician in cardiology and metabolic management walks through a presentation on identifying, addressing, and continually treating for heightened cardiometabolic risk.

Cardiometabolic Risk Evaluation with Brett Nowlan, MD

The association between genetic liability to smoking and ASCVD was independent from the effects of smoking on traditional cardiovascular risk factors. 


Genetic Liability to Smoking Linked to Atherosclerotic Cardiovascular Disease

While often referred to as "Good cholesterol" new research suggests HDL measurements do little for predicting risk of heart attack in Black patients

HDL Cholesterol Not As Useful for Predicting MI in Minority Patients

A new study from the University of Arizona is shedding light on the psychological impact of Tai Chi in patients with cardiovascular disease.

Tai Chi Improves Mental Well-Being of Patients with Cardiovascular Disease

A new analysis examines impact of treatment adherence in more than 1.2 million patients. 

Blood Pressure Treatment Adherence Reduces Mortality, Regardless of Frailty

The expanded indication is the first regulatory approval for aspirin plus ticagrelor dual antiplatelet therapy in those with a high risk, but no history of heart attack or stroke.

FDA Approves Ticagrelor DAPT for Patients Without CVD, Stroke History

Discussing the results of a recent analysis that estimated the impact of comprehensive therapy with SGLT2 inhibitors, ARNIs, and MRAs in patients with HFrEF.

Muthiah Vaduganathan, MD: Real-World Impact of Comprehensive HFrEF Therapy

The latest scientific statement from the American Heart Association examines disparities in risk factors, social determinants of health, and management approaches for these patients. 

AHA Seeks to Address Health Disparities in American Indians, Alaska Natives

A new analysis of the DASH trial found a fruit-and-vegetable diet was associated with lower levels of hs-cTnl and NT-proBNP. 

Diets Rich in Fruits and Vegetables Lower Cardiac Strain, Damage

On the HCPLive atherosclerosis page, resources on the topics of medical news and expert insight into ASCVD can be found. Content includes articles, interviews, videos, podcasts, and breaking news on atherosclerotic disease, and more.

Atherosclerosis

Latest News